BrainsWay Ltd. (BWAY)
Uses magnetic pulses to treat depression and other brain disorders without surgery.
$15.49-0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+170.1%
The outlook
BWAY is trading at $15.49 with all three analysts rating it Strong Buy. The stock sits well above both its 50- and 200-day moving averages and is positioned near the upper end of its 52-week range. The average analyst price target implies roughly 14% upside from current levels.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range84% of the way from its 52-week low to high
Price targetAvg target +14% vs current price
Analyst price target
~12-month · 3 analysts$17.67average target+14.1% vs now
Now $15.49
Low $17.00High $18.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$621.6M
52-wk high
$17.35
52-wk low
$5.68
50-day avg
$15.04
200-day avg
$12.29
Trailing P/E
73.8